Mikhail Eydelman
Oficial de Cumplimiento en VAXCYTE, INC. .
Fortuna: 2 M $ al 31/05/2024
Perfil
Mikhail Eydelman is currently working as the Secretary, Chief Compliance Officer & Senior VP at Vaxcyte, Inc. He previously worked as the Secretary & General Counsel at Sagent Pharmaceuticals, Inc. from 2017 to 2022.
Mr. Eydelman completed his undergraduate degree at Brandeis University and his graduate degree at New York University School of Law.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VAXCYTE, INC.
0.03% | 07/06/2024 | 30 826 ( 0.03% ) | 2 M $ | 31/05/2024 |
Cargos activos de Mikhail Eydelman
| Empresas | Cargo | Inicio |
|---|---|---|
| VAXCYTE, INC. | Oficial de Cumplimiento | 01/04/2022 |
Antiguos cargos conocidos de Mikhail Eydelman.
| Empresas | Cargo | Fin |
|---|---|---|
| SAGENT PHARMACEUTICALS INC | Consejero General | 01/04/2022 |
Formación de Mikhail Eydelman.
| Brandeis University | Undergraduate Degree |
| New York University School of Law | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| VAXCYTE, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Sagent Pharmaceuticals, Inc.
 Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Mikhail Eydelman
